Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia
-
- YUASA Mitsuhiro
- Department of Hematology, Toranomon Hopital
-
- ISHIWATA Kazuya
- Department of Hematology, Toranomon Hopital
-
- SUGIO Takeshi
- Department of Hematology, Toranomon Hopital
-
- KAJI Daisuke
- Department of Hematology, Toranomon Hopital
-
- OTA Hikari
- Department of Hematology, Toranomon Hopital
-
- TSUJI Masanori
- Department of Hematology, Toranomon Hopital
-
- YAMAMOTO Hisashi
- Department of Hematology, Toranomon Hopital
-
- YAMAMOTO Go
- Department of Hematology, Toranomon Hopital
-
- ASANO-MORI Yuki
- Department of Hematology, Toranomon Hopital
-
- UCHIDA Naoyuki
- Department of Hematology, Toranomon Hopital
-
- IZUTSU Koji
- Department of Hematology, Toranomon Hopital
-
- TANIGUCHI Shuichi
- Department of Hematology, Toranomon Hopital
Bibliographic Information
- Other Title
-
- 急性骨髄性白血病に対する臍帯血移植後に生じた単純ヘルペスウイルス2型による劇症肝炎
- 症例報告 第170回日本血液学会例会:谷口修一例会長 推薦演題 急性骨髄性白血病に対する臍帯血移植後に生じた単純ヘルペスウイルス2型による劇症肝炎
- ショウレイ ホウコク ダイ170カイ ニホン ケツエキ ガッカイ レイカイ:タニグチ シュウイチレイ カイチョウ スイセン エンダイ キュウセイ コツズイセイ ハッケツビョウ ニ タイスル サイタイケツ イショク ゴ ニ ショウジタ タンジュンヘルペスウイルス 2ガタ ニ ヨル ゲキショウ カンエン
Search this article
Description
This report describes a 41-year-old patient, who developed herpes simplex virus type 2 (HSV-2)-hepatitis after umbilical cord blood transplantation (CBT). The patient had received allogeneic bone marrow transplantation from an unrelated donor for acute myeloid leukemia (AML) not in remission. AML relapsed 18 months after the first transplantation, and CBT was performed. AML relapsed again 5 months later and the patient was given chemotherapy. Although there was no active chronic graft-versus-host disease, liver dysfunction appeared, and one week later, progressed to acute liver failure. Viral screening of blood by PCR including hepatitis B and C viruses, human immunodeficiency virus, Epstein-Barr virus, cytomegalovirus, herpes simplex virus type 1 and HSV-2 revealed elevation of HSV-2 (2.34×104 copies/ml). We diagnosed the patient as having HSV-2 acute hepatitis, and initiated treatment with antiviral drugs (acyclovir, foscarnet) and plasma exchange. However, liver functions deteriorated rapidly, and the patient died on day 6 after the onset of acute liver failure. Although HSV hepatitis is very rare after allogeneic stem cell transplantation, it is rapidly progressive and associated with a high mortality rate. Thus, early diagnosis with prompt antiviral intervention is recommended.
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 55 (6), 682-686, 2014
The Japanese Society of Hematology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282680013939456
-
- NII Article ID
- 130004501871
-
- NII Book ID
- AN00252940
-
- COI
- 1:STN:280:DC%2BC2cfnvFehsw%3D%3D
-
- ISSN
- 18820824
- 04851439
-
- NDL BIB ID
- 025613218
-
- PubMed
- 24975337
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed